Patient Square Capital’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$523K	Buy	317,033 +60,000	+23%	+$99K	0.19%	19
2025 Q1	$406K	Buy	+257,033	New	+$406K	0.17%	19